Emerging Molecular Agents Target VEGF In Treatment Of AMD

Wednesday, March 18, 2009

Comments

Ocular Surgery News

Amid studies on the safety and effectiveness of anti-VEGFs for age-related macular degeneration, researchers are developing genetic and molecular agents that target the VEGF cascade, a speaker said here.

Full Story

Retina Products and Equipment »

Ectopia lentis in a patient with Marfan’s syndrome is characteristically in which direction:
1. inferotemporal
2. inferonasal
3. superotemporal
4. superonasal
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Emerging Molecular Agents Target VEGF In Treatment Of AMD

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

Ectopia lentis in a patient with Marfan’s syndrome is characteristically in which direction:

AdGlare RMR Ad

Featured Products

3nethra classic Ophthalmic Imaging Device

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us